Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: A longitudinal study
European Journal of Cancer, 10/15/09
Collins S et al. – Current smoking intensity is an independent risk factor for high-grade CIN in young women, after controlling for cervical HPV infection.
Methods- Longitudinal analysis
- 1485 women aged 15–19 y
- 1075 HPV-negative and cytologically normal at recruitment
- 410 HPV-positive, cytologically abnormal or both
- Women re-attended every 6 mos, when samples were taken for cytological and virological examination
- Current smoking intensity associated with increased risk of high-grade CIN, after controlling for cervical HPV status
- In those HPV-negative and cytologically normal at recruitment, current smoking not significantly associated with risk of acquiring cervical HPV infection, after controlling for life-time number of partners and age of oldest partner (HR=1.13, 95% CI 0.90–1.41); nor did it prolong length of time during which HPV could be detected
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Ovarian cancer screening and early detection
Women's Health, 11/04/09
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia
New England Journal of Medicine, 11/06/09
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: A phase 3, open-label, randomised controlled trial
The Lancet, 11/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


